Department of Plastic and Reconstructive Surgery, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.
Bio-X Institute, Shanghai Jiao Tong University, Shanghai, PR China.
Hereditas. 2020 Jul 7;157(1):27. doi: 10.1186/s41065-020-00143-z.
Capillary malformation-arteriovenous malformations (CM-AVMs) caused by a RASA-1 or EPHB4 mutation are characterized as hereditary sporadic or multifocal capillary malformations (CMs), associated with potential fast-flow vascular anomalies underlying erythema lesions. Because of the similar phenotype, CM-AVMs should be considered in the differential diagnosis of isolated CMs as well as other disorders with an erythema phenotype, such as hereditary hemorrhagic telangiectasia (HHT).Herein, we report a male patient with facial erythema. Red lesions were located in the V1 region of his left face, the V2 and V3 regions on his right side, and the nasal back. The patient was initially thought to have PWSs because of the unilateral and segmental distribution of his red facial lesions. In contrast to a previous diagnosis, we diagnosed the child with capillary malformation-arteriovenous malformation type 2 (CM-AVM2) based on a family history of erythema, the results of physical examination and ultrasound raising potential fast-flow lesions, and a genetic study revealing a germline EPHB4 mutation. This study emphasizes the importance of differential diagnosis for PWS and CM-AVM. A single clinical diagnosis can be limited, and molecular diagnosis is recommended to provide more information for the evaluation of the potential risk of fast-flow lesions underlying erythema lesions if necessary.
由 RASA-1 或 EPHB4 突变引起的毛细血管畸形-动静脉畸形(CM-AVM)的特征是遗传性散发性或多灶性毛细血管畸形(CM),伴有红斑病变下潜在的快速血流血管异常。由于表型相似,CM-AVM 应在鉴别诊断孤立性 CM 以及其他具有红斑表型的疾病时考虑,例如遗传性出血性毛细血管扩张症(HHT)。在此,我们报告了一名面部红斑的男性患者。他的左侧面部 V1 区域、右侧 V2 和 V3 区域以及鼻背部均有红色病变。由于患者红色面部病变的单侧和节段性分布,最初被认为患有 PWS。与先前的诊断不同,我们根据家族史中的红斑、体格检查和超声结果提示潜在的快速血流病变以及遗传研究发现种系 EPHB4 突变,诊断该患儿为毛细血管畸形-动静脉畸形 2 型(CM-AVM2)。该研究强调了 PWS 和 CM-AVM 进行鉴别诊断的重要性。单一的临床诊断可能存在局限性,建议进行分子诊断,以便在必要时为评估红斑病变下潜在的快速血流病变的风险提供更多信息。